II. Definitions
- Central Retinal Artery Occlusion (CRAO)
- Central Retinal artery is occluded affecting all Visual Fields
- Branch Retinal Artery Occlusion (BRAO)
- Branches of central Retinal artery are occluded, with segmental Vision Loss
III. Epidemiology
- Annual Incidence: One per 100,000 (U.S.)
- Age (mean): 60 years old
IV. Pathophysiology
-
Retinal vascular supply
- Central Retinal artery
- Supplied by opthalmic artery (branch of the Internal Carotid Artery)
- Cilioretinal artery (only present in 30% of patients)
- Central Retinal artery
- Causes: Ophthalmic Artery Occlusion
- See Transient Ischemic Attack
- Embolism to Retinal artery (most common CRAO cause)
- Cholesterol or thrombotic emboli (esp. Atrial Fibrillation)
- Temporal Arteritis (<5% of CRAO cases) or other Vasculitis
- Hypoperfusion
- Hemodialysis
- Severe shock
- Nocturnal artery Hypotension (awake with Vision Loss)
- Associated with Antihypertensives taken near bedtime
- Other causes
- Thrombosis, inflammation or Eye Trauma
V. Risk Factors
- Age over 70 years
- Atrial Fibrillation
- Cardiovascular disease risks
- Migraine Headaches
- Collagen vascular disease (e.g. Systemic Lupus Erythematosus)
- Temporal Arteritis
- Sickle Cell Anemia
VI. Symptoms
- See Transient Monocular Blindness (Amaurosis Fugax)
- Painless acute unilateral Vision Loss
- More than half of patients have only hand motion and light Perception
- CRAO causes Vision Loss over entire Visual Field, while BRAO results in focal Vision Loss
- May be preceded by prior episode of Amaurosis Fugax
- May be associated with other focal neurologic deficits
- See Transient Ischemic Attack
- Affects ipsilateral Carotid Artery circulation
VII. Signs
-
Visual Acuity severely reduced to counting fingers, hand motion or light Perception only
- Branch Retinal Artery Occlusion (BRAO) may present with Visual Field cut
- Perform full Visual Field testing (differentiates CRAO from BRAO)
-
Relative Afferent Pupillary Defect
- Pupil dilated with slow reaction (but preserved Consensual Light Reaction)
- Fundoscopic exam
- Retina appears pale-gray or white due to Retinal edema
- Macula with cherry-red spot on white-yellow background (collateral circulation from Choroid)
- Constricted arterioles
- Box-Carring of Retinal vessels
- Retinal vessels with interrupted columns of blood appear as train box cars
- Blood cells separate from serum
- Hollenhorst Plaques (white punctate Cholesterol emboli)
- "Glistening orange yellow flakes"
- Represent fragmented emboli at arteriole bifurcations
- Remainder of Eye Exam is normal
- Normal Extraocular Movement
- Normal ocular pressure
- Normal anterior chamber
- Neck Exam
VIII. Exam
- Vital Signs including Blood Pressure
- Complete Neurologic Exam
- Include NIH Stroke Scale
- Cardiovascular Exam
- Complete Eye Exam
- See Acute Vision Loss
- See Eye Vital Signs
- Visual Fields and Visual Acuity testing drive management and prognosis
IX. Differential Diagnosis
- See Acute Vision Loss
- Central Retinal Vein Occlusion
- Retinal Detachment
- Vitreous Hemorrhage
- Acute Angle Closure Glaucoma
X. Precautions
- Central Retinal Artery Occlusion (CRAO) is a stroke of the eye
- Evaluate as Cerebrovascular Accident (code stroke in hyperacute presentations)
- In some centers, CRAO presenting within first 4.5 hours, is treated with tPA
XI. Labs
-
Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (cRP)
- Increased in Temporal Arteritis
-
Cerebrovascular Accident Evaluation
- Acute Retinal Artery Occlusion is managed as an acute eye CVA and typically involves CVA-related lab testing
- Complete Blood Count with Platelets
- Comprehensive Metabolic Panel
- Coagulation Studies (INR, PTT)
- Lipid Panel
- Hemoglobin A1C
XII. Diagnostics
-
Electrocardiogram
- Evaluate for Atrial Fibrillation
-
Echocardiogram
- Evaluate as performed in CVA and TIA
XIII. Imaging: Acute
-
CT Head and CT Angiogram Head and Neck
- Evaluate as Transient Ischemic Attack or CVA (depending on deficits and timing)
- Performed as stat CVA imaging in acute presentations
-
MRI Brain with Diffusion Weighted Imaging
- Consider for other associated embolic lesions, or in delayed presentations
- Include MR Angiogram if CT angiogram not already performed
-
Orbital Ultrasound
- Exclude alternative diagnoses of Acute Vision Loss (Retinal Detachment, Vitreous Hemorrhage)
- Central Retinal artery loss of Doppler Ultrasound signal
- Retrobulbar spot sign
- Test Sensitivity: 59%
- Hyperechoic dot within central Retinal artery
- Positive in cases in which thromboembolic material is calcified
- Calcified emboli are poorly responsive to TPA
- References
- Broder (2021) Crit Dec Emerg Med 35(11): 12-3
- Nedelmann (2015) Stroke 46: 2322-4 [PubMed]
- Riccardi (2016) J Emerg Med 50: e183-5 [PubMed]
XIV. Management: General
- Manage in similar fashion to a stroke protocol (code stroke)
- Follow stroke evaluation with stat head imaging, ekg, labs for acute presentations
- Consider Thrombolytics in hyperacute presentations within 4.5 to 6 hours (see below)
- Emergent Ophthalmology Consultation without delay
- Irreversible Vision Loss begins in the first 90-120 minutes
-
Temporal Arteritis (ESR or CRP meet criteria)
- See Temporal Arteritis
- Start empiric Corticosteroids
- Temporal artery biopsy or Doppler Ultrasound
XV. Management: Thrombolytics and Cerebrovascular Management
- Approach CRAO as a "stroke to the eye"
- Evaluate patients age <50 years old for Hypercoagulable state causes (e.g. Antiphospholipid Antibody Syndrome)
- Manage as acute CVA in presentations within 4.5 to 6 hours (considering tPA or TNK)
- Stroke neurologists and ophthalmologists recommend systemic Thrombolytics for CRAO in some centers
- Limited and mixed evidence, but >50% recovery with Thrombolytic use
- References
- Bustamante (2024) Eur Stroke J 9(2):486-93 +PMID: 38189284 [PubMed]
- Page (2018) Front Neurol 9:76 +PMID: 29527185 [PubMed]
- CRAO: Promising Results From Emergency Protocols (AAO)
XVI. Management: Lower Intraocular Pressure or dislodge Occlusion
- Precautions
- Thrombolytics in the first 4.5 hours have the best evidence and these other measures are adjunctive only
- Hyperbaric oxygen may be considered where available
- Many of the historic measures in this list lack modern evidence of benefit, and are not recommended
- Balloting the eye
- Ocular Paracentesis
- Measures with supporting evidence
- Hyperbaric oxygen
- May improve Retinal oxygenation by increasing passive Choroidal oxygenation
- Reasonable to consider if available at treating facility
- Murphy-Lavole (2012) Undersea Hyperb Med 39(5): 943-53 +PMID: 23045923 [PubMed]
- Hyperbaric oxygen
- Other Measures with evidence lacking
- Lie patient supine with both Eyelids closed
- Ballot the eye: Apply intermittent pressure to eyeball
- Emergently perform as soon as possible
- Offers benefit within 6 hours (possibly up to 24 hours)
- Massage the globe with index fingers or each hand, then release suddenly
- Apply pressure in repeated cycles of 5-10 seconds on and 5 seconds off
- Perform for 20 cycles total or from 5-30 minutes
- Goal is to dislodge a thrombus
- Aqueous outflow increases with eye pressure
- Retinal perfusion increases with release of eye pressure
- Emergently perform as soon as possible
- Ocular Paracentesis
- Ophthalmologist aspirates 0.1 to 0.4 ml anterior chamber fluid via 27-30 gauge needle
- Goal to reduce Intraocular Pressure and shift the embolism distally
- May offer benefit up to 24 hours after onset
- Consider Hypercarbia
- Patient rebreathes into a paper bag for 10 minutes of each hour OR
- Inhalation of mix of 5% carbon dioxide and 95% oxygen
- Goal is to result in eye vessel vasodilation due to increased carbon dioxide concentrations
- Consider Aqueous Humor production strategies
- Mannitol 1 g/kg IV for 1 dose AND Acetazolamide 500 mg IV for 1 dose OR
- Acetazolamide 500 mg orally for 1 dose
- Other measures that have been used (discuss with ophthalmology)
- Timolol maleate (0.5%) one drop topically
- Pilocarpine drops to eye
- Oral Nitroglycerin
- Pentoxifylline (Trental) three 600 mg tablets daily
- Laser arteriotomy
- Embolectomy
XVII. Prognosis
- Vision Loss risk increases after 90 minutes (and esp. after 4 hours) of arterial Occlusion
- Spontaneous visual improvement may occur in first 7 days after onset
- Final Visual Acuity in affected eye <20/400
XVIII. References
- Hartmann (2016) Crit Dec Emerg Med 30(6): 3-11
- Swaminathan and Marcolini (2025) Central Retinal Artery Occlusion, 2/17/2025
- Sales, Patel and Patel (2019) Crit Dec Emerg Med 33(12): 3-13
- Werner and St Peter in Herbert (2021) 21(9): 13-4
- Beatty (2000) J Accident Emerg Med 17:324-9 [PubMed]
- Biousse (2018) Ophthalmology 125:1597-607 [PubMed]
- Gelston (2020) Am Fam Physician 102(9):539-45 [PubMed]
- Pokhrel (2007) Am Fam Physician 76:829-36 [PubMed]